Skip to content
PolarisQB
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us
PolarisQB Logo
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us

Press Release

  • PolarisQB Receives DARPA EEI Award to Advance Quantum Computing for Drug Design
    October 2nd, 2025· 1.8 min·
    PolarisQB Receives DARPA EEI Award to Advance Quantum Computing for Drug Design

    DURHAM, NC - The Defense Advanced Research Projects Agency (DARPA)

  • Polaris Quantum Biotech Unveils QuADD: Next-Generation Quantum-AI Drug Discovery Platform – Beta Testers Wanted
    August 12th, 2025· 2.7 min·
    Polaris Quantum Biotech Unveils QuADD: Next-Generation Quantum-AI Drug Discovery Platform – Beta Testers Wanted

    DURHAM, NC - Polaris Quantum Biotech (PolarisQB), a leader in

  • PolarisQB Announces the Addition of Board Member Anat Naschitz
    May 7th, 2024· 2.5 min·
    PolarisQB Announces the Addition of Board Member Anat Naschitz

    POLARISqb, a company revolutionizing drug design by joining quantum computing

  • PolarisQB and Scientist.com Partner to Offer Online Access to Quantum-Aided Drug Design, the first Quantum-Enabled Drug Discovery Platform
    January 16th, 2024· 2 min·
    PolarisQB and Scientist.com Partner to Offer Online Access to Quantum-Aided Drug Design, the first Quantum-Enabled Drug Discovery Platform

    POLARISqb, the first company to build quantum-enabled molecular optimization tools

  • March 16th, 2020· 0.2 min·
    POLARISqb and Fujitsu

    [vc_row][vc_column][vc_column_text] POLARISqb and Fujitsu announces pioneering drug discovery platform to speed up the

Search
Recent Posts
  • PolarisQB Receives DARPA EEI Award to Advance Quantum Computing for Drug Design October 2, 2025
  • Polaris Quantum Biotech Unveils QuADD: Next-Generation Quantum-AI Drug Discovery Platform – Beta Testers Wanted August 12, 2025
  • An Investigation of Allostery in Epidermal Growth Factor Receptor Using Sextant with Dynamics Simulations to Expand an Apo Site February 28, 2025
Categories
  • Blog (14)
  • News (45)

Why Quantum

Quantum Computing Today
Quantum vs. Traditional Screening
Quantum vs. AI

QuADD Solutions

Hits & Leads
Joint Development
Pipeline
Platform

Who We Serve

Pharma
Biotech
Agriculture
CROs

Resources

Blog
Whitepapers
Webinars
Publications

Company

About Us
Customers
Partners
News
Team
Contact

212 W Main St
Suite 200 PMB 205
Durham, NC 27701

info@polarisqb.com
919.200.0592

© 2025 All Rights Reserved | Privacy Policy | Terms of Use

Page load link
Go to Top